PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-12-14

Date Title Company
14-Dec-2022 DNA Synthesis Market is predicted to advance at a CAGR of 7.7% from 2022 to 2032 MARKITWIRED
14-Dec-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
14-Dec-2022 Ribonexus appoints Steven Powell as CEO Andrew Lloyd Associates
14-Dec-2022 Pathology Imaging Systems Market is anticipated to register a CAGR of 10.3% during the forecast period. MARKITWIRED
14-Dec-2022 Dermatology Cryosurgery Units Market is expected to reach US$ 305.7 Million by 2032 MARKITWIRED
14-Dec-2022 ABBOTT AND THE BRAIN INJURY ASSOCIATION OF AMERICA LAUNCH CONCUSSION AWARENESS NOW COALITION; TEAM UP WITH REBEL WILSON TO RAISE AWARENESS ON SERIOUSNESS OF CONCUSSIONS ABBOTT
14-Dec-2022 GSK and Wave Life Sciences announce collaboration to drive discovery and development of oligonucleotide therapeutics focusing on novel genetic targets GSK
14-Dec-2022 JT Group Recognized on CDP’s “Climate Change A List” for the 4th Consecutive Year Businesswire
14-Dec-2022 Apogenix Enrolls First Patients in Pivotal Phase III Trial for the Treatment of Hospitalized COVID-19 Patients with Asunercept Apogenix AG
14-Dec-2022 Cancellation of remaining publicly held registered shares of Vifor Pharma AG Businesswire
14-Dec-2022 Etcembly Announces Breakthrough in Optimising TCR Assets Etcembly
14-Dec-2022 STORM Therapeutics announces closing of USD $30M Series B financing STORM Therapeutics
14-Dec-2022 Poolbeg exclusively licences innovative oral delivery technology for metabolic syndrome related diseases Poolbeg Pharma
14-Dec-2022 Aston University biochemist explains why oxygen is an essential but stressful element - public lecture Aston University
14-Dec-2022 Evolva launches its Natural Nootkatone Evolva Holding SA
14-Dec-2022 Relief Therapeutics to Participate in January Investor Meetings Relief Therapeutics Holding SA
14-Dec-2022 Cosmo announces successful Phase III clinical trial of Lumeblue™ in China Cosmo Pharmaceuticals N.V.
14-Dec-2022 TWIST ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Twist Bioscience Corp and Encourages Investors to Contact the Firm Businesswire
14-Dec-2022 Epigenomics Releases Performance Data on Next Generation Test Epigenomics AG
14-Dec-2022 Epigenomics Licenses Protein Biomarker Technology for Blood-based Colorectal Cancer Test Epigenomics AG